These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19204831)

  • 21. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.
    Xu DQ; Cisar JO; Ambulos N; Burr DH; Kopecko DJ
    Infect Immun; 2002 Aug; 70(8):4414-23. PubMed ID: 12117952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype.
    Mitobe J; Sinha R; Mitra S; Nag D; Saito N; Shimuta K; Koizumi N; Koley H
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005728. PubMed ID: 28727722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
    DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preliminary observation on antitumor effect of HPV58 composite DNA vaccine].
    Wang H; Yu JY; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):523-7. PubMed ID: 24284225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carboxyl terminus truncated human papillomavirus type 58 L1 protein maintains its bioactivity and ability to form virus-like particles.
    Li W; Liu H; Zheng J; Chen H; Yang J; Wang L; Yan X; Wang Y; Si L
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(6):537-9. PubMed ID: 15791833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live-attenuated Shigella vaccines.
    Venkatesan MM; Ranallo RT
    Expert Rev Vaccines; 2006 Oct; 5(5):669-86. PubMed ID: 17181440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.
    Baud D; Ponci F; Bobst M; De Grandi P; Nardelli-Haefliger D
    J Virol; 2004 Dec; 78(23):12901-9. PubMed ID: 15542642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains.
    Hartman AB; Powell CJ; Schultz CL; Oaks EV; Eckels KH
    Infect Immun; 1991 Nov; 59(11):4075-83. PubMed ID: 1937767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions.
    Bedford L; Fonseka S; Boren T; Ranallo RT; Suvarnapunya AE; Lee JE; Barnoy S; Venkatesan MM
    Gut Microbes; 2011; 2(4):244-51. PubMed ID: 21983066
    [No Abstract]   [Full Text] [Related]  

  • 34. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
    J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector.
    Fennelly GJ; Khan SA; Abadi MA; Wild TF; Bloom BR
    J Immunol; 1999 Feb; 162(3):1603-10. PubMed ID: 9973419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.
    Qi Z; Zhou L; Zhang Q; Ren L; Dai R; Wu B; Wang T; Zhu Z; Yang Y; Cui B; Wang Z; Wang H; Qiu Y; Guo Z; Yang R; Wang X
    Vaccine; 2010 Feb; 28(6):1655-60. PubMed ID: 20079562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-protection provided by live Shigella mutants lacking major antigens.
    Szijártó V; Hunyadi-Gulyás E; Emődy L; Pál T; Nagy G
    Int J Med Microbiol; 2013 May; 303(4):167-75. PubMed ID: 23567193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shigella vaccine development: prospective animal models and current status.
    Kim YJ; Yeo SG; Park JH; Ko HJ
    Curr Pharm Biotechnol; 2013; 14(10):903-12. PubMed ID: 24372251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae.
    Nag D; Koley H; Sinha R; Mukherjee P; Sarkar C; Withey JH; Gachhui R
    Scand J Immunol; 2016 Feb; 83(2):92-101. PubMed ID: 26478541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental study of the immuno-protective activity of recombinant vaccinia virus expressing HPV58 E7].
    Luo LQ; Li J; Liu X; Zhang YH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):43-6. PubMed ID: 12905606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.